View Clinical Trial (Medical Research Study)
Novel Diagnostics With Optical Coherence Tomography: Retinal Imaging
| City: |
|
Pittsburgh |
| State: |
|
Pennsylvania |
| Zip Code: |
|
15213 |
| Conditions: |
|
Macular Degeneration - Glaucoma - Diabetic Retinopathy. |
| Purpose: |
|
The purpose of this research is to evaluate optical coherence tomography (OCT) and FDA
approved device used to image diseases of the eye. The ultra-high resolution OCT is a
non-significant risk device used in this study. Optical Coherence Tomography may be useful
for early diagnosis and monitoring of different types of eye diseases.
|
| Study Summary: |
|
The purpose of this research is to evaluate optical coherence tomography (OCT) and FDA
approved device used to image diseases of the eye. The ultra-high resolution OCT is a
non-significant risk device used in this study. OCT may be useful for early diagnosis and
monitoring of different types of eye diseases.
|
| Criteria: |
|
Inclusion Criteria:
- Subjects with healthy eyes, macular degeneration, glaucoma and other various eye
diseases. Also must be able to fixate on target.
Exclusion Criteria:
- If the fundus is not visible if the media is opaque and if they are unwilling to
participate.
|
| NCT ID: |
|
NCT00343746 |
| Primary Contact: |
|
Study Chair
Joel S Schuman, MD
University of Pittsburgh
Kristy A Truman
Phone: 412-383-8778
Email: trumank@upmc.edu
|
| Backup Contact: |
|
Email: salaymd@upmc.edu
Melessa Slaay, COA
Phone: 412-383-9884
|
| Location Contact: |
|
Pittsburgh, Pennsylvania 15213
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|